Hims & Hers Health, Inc. (HIMS) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-17 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-07-17 | Code: M (Exercise of derivative) Shares: +7,163 | Price: $5.01 Total Value: $35,886.63 Shares Owned After: 291,484 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [Transaction #2] Security: Class A Common Stock Date: 2026-07-17 | Code: S (Open market sale) Shares: -7,163 | Price: $31.99 Total Value: $229,168.01 Shares Owned After: 284,321 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F2] Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (right to buy) Date: 2026-07-17 | Code: M (Exercise of derivative) Shares: -7,163 | Price: $0.00 Exercisable: N/A | Expires: 2032-02-23 Shares Owned After: 95,198 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. [F3] 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.93 - $32.06. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-07-20)